Neurology & Pain Management
Neuropathic Pain Clinical Research
Neuropathic pain affects millions of people worldwide and can significantly impact quality of life. CenExel partners with sponsors to advance innovative therapies for chronic nerve pain conditions through specialized clinical research, experienced investigators, and diverse patient populations.
Advancing Research in Neuropathic Pain Treatment
CenExel’s neuropathic pain research network supports complex clinical trials focused on chronic nerve-related pain disorders. Our experienced investigators and operational teams deliver high-quality data, rapid enrollment, and patient-centered care across all study phases.
Specialized Pain Research
Faster Trial Enrollment
Neuropathic Pain Conditions We Research
Our research sites support a broad range of neuropathic pain studies across central and peripheral nervous system disorders.
- Diabetic Peripheral Neuropathy
- Post-Herpetic Neuralgia
- Fibromyalgia
- Sciatica & Radiculopathy
- Chronic Lower Back Nerve Pain
- Chemotherapy-Induced Neuropathy
- Trigeminal Neuralgia
- Complex Regional Pain Syndrome (CRPS)
Why Sponsors Choose CenExel for Neuropathic Pain
CenExel combines scientific expertise, operational efficiency, and patient-focused strategies to support successful neuropathic pain clinical trials.
01
Experienced Pain Investigators
Dedicated investigators with deep expertise in chronic pain and neurology-focused clinical trials.
02
Diverse Patient Access
Broad patient databases and outreach strategies support rapid recruitment and retention.
03
Centralized Trial Operations
Streamlined study management and standardized workflows improve trial consistency.
04
Reliable Study Performance
Strong enrollment metrics and high-quality data collection help sponsors meet study goals efficiently.
Supported Neuropathic Pain Trial Phases
CenExel supports early and late-phase neuropathic pain studies — from first-in-human research through Phase IV post-market studies.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our experienced teams support biomarker-driven studies, pain scoring methodologies, patient-reported outcomes, and long-term safety monitoring.
Neuropathic Pain Task Force
CenExel supports sponsors with specialized neuropathic pain research capabilities, experienced investigators, centralized recruitment strategies, and scalable site operations designed to improve trial performance.






